UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (774) 774
science & technology (710) 710
life sciences & biomedicine (639) 639
male (476) 476
aniline compounds - adverse effects (429) 429
female (409) 409
animals (376) 376
middle aged (253) 253
adult (250) 250
aniline compounds - therapeutic use (234) 234
aged (197) 197
aniline compounds - pharmacology (188) 188
aniline (153) 153
rats (150) 150
oncology (137) 137
aniline compounds - administration & dosage (131) 131
mice (129) 129
aniline compounds (115) 115
aniline compounds - chemistry (108) 108
aniline compounds - toxicity (105) 105
pharmacology & pharmacy (105) 105
toxicology (105) 105
analysis (90) 90
environmental sciences & ecology (87) 87
aged, 80 and over (86) 86
environmental sciences (86) 86
physical sciences (84) 84
antineoplastic agents - therapeutic use (82) 82
dose-response relationship, drug (78) 78
aniline compounds - pharmacokinetics (75) 75
chemistry (73) 73
abridged index medicus (72) 72
protein kinase inhibitors - therapeutic use (72) 72
antineoplastic agents - adverse effects (69) 69
time factors (69) 69
cancer (65) 65
treatment outcome (65) 65
protein kinase inhibitors - adverse effects (63) 63
aniline compounds - metabolism (60) 60
coloring agents - adverse effects (58) 58
mutation (58) 58
adolescent (57) 57
clinical trials as topic (57) 57
nitriles - adverse effects (57) 57
quinolines - adverse effects (57) 57
technology (57) 57
quinolines - therapeutic use (55) 55
research (53) 53
administration, oral (52) 52
care and treatment (52) 52
nitriles - therapeutic use (52) 52
medicine & public health (50) 50
toxicity (50) 50
lung neoplasms - drug therapy (48) 48
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (47) 47
bosutinib (46) 46
tyrosine (46) 46
neurosciences & neurology (45) 45
carcinoma, non-small-cell lung - drug therapy (44) 44
young adult (44) 44
hematology (43) 43
antineoplastic agents - pharmacology (42) 42
engineering (41) 41
rats, sprague-dawley (41) 41
alzheimer's disease (40) 40
alzheimer disease - diagnostic imaging (38) 38
biochemistry & molecular biology (37) 37
positron-emission tomography (37) 37
apoptosis (36) 36
neurosciences (36) 36
protein kinase inhibitors - administration & dosage (36) 36
apoptosis - drug effects (35) 35
public, environmental & occupational health (35) 35
dermatology (34) 34
disease models, animal (34) 34
health aspects (34) 34
leukemia (34) 34
liver - drug effects (34) 34
research article (34) 34
drug therapy (33) 33
lung cancer (33) 33
occupational diseases - chemically induced (33) 33
occupational exposure - adverse effects (33) 33
protein kinase inhibitors - pharmacology (33) 33
pyrimidines - therapeutic use (33) 33
aniline compounds - analysis (32) 32
antineoplastic agents - administration & dosage (32) 32
calcium - metabolism (32) 32
erbb receptors - genetics (32) 32
carcinogens (31) 31
cell biology (31) 31
cell line, tumor (31) 31
chronic myeloid leukemia (31) 31
pyrimidines - adverse effects (31) 31
brain - diagnostic imaging (30) 30
chemotherapy (30) 30
old medline (30) 30
patients (30) 30
chemical industry (29) 29
neoplasms - drug therapy (29) 29
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1048) 1048
German (48) 48
Russian (30) 30
French (20) 20
Italian (13) 13
Japanese (13) 13
Chinese (11) 11
Polish (6) 6
Spanish (4) 4
Portuguese (2) 2
Romanian (2) 2
Swedish (2) 2
Bulgarian (1) 1
Czech (1) 1
Dutch (1) 1
Norwegian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British journal of haematology, ISSN 0007-1048, 01/2015, Volume 168, Issue 1, pp. 69 - 81
Summary Bosutinib is an oral, dual SRC/ABL1 tyrosine kinase inhibitor for resistant/intolerant chronic myeloid leukaemia (CML). We assessed the efficacy and... 
BCR‐ABL1 | CML | tyrosine kinase inhibitor | bosutinib | chronic myeloid leukaemia | Chronic myeloid leukaemia | Tyrosine kinase inhibitor | Bosutinib | BCR-ABL1 | Life Sciences & Biomedicine | Hematology | Science & Technology | Index Medicus | Haematological Malignancy
Journal Article
Journal Article
Journal of the American Society of Nephrology, ISSN 1533-3450, 09/2017, Volume 28, Issue 9, pp. 2756 - 2767
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 02/2012, Volume 30, Issue 5, pp. 488 - 496
Journal Article
Journal Article
Blood, ISSN 1528-0020, 02/2014, Volume 123, Issue 9, pp. 1309 - 1318
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2015, Volume 372, Issue 18, pp. 1689 - 1699
AZD9291, an irreversible inhibitor of epidermal growth factor receptor, was associated with tumor responses in the majority of patients with advanced... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Humans | Middle Aged | ErbB Receptors - genetics | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Acrylamides - pharmacokinetics | Dose-Response Relationship, Drug | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Aniline Compounds - administration & dosage | Lung Neoplasms - genetics | Protein Kinase Inhibitors - pharmacokinetics | ErbB Receptors - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - genetics | Aniline Compounds - pharmacokinetics | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Acrylamides - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Aniline Compounds - adverse effects | Acrylamides - adverse effects | Clinical trials | Care and treatment | Usage | Diagnosis | Lung cancer, Non-small cell | Patient outcomes | Tyrosine | Appetite | Inhibitor drugs | Epidermal growth factor receptors | Lung cancer | Diarrhea | Nausea | Drug resistance | Kinases | Patients | Epidermal growth factor | Pharmacokinetics | Protein-tyrosine kinase | Index Medicus | Abridged Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 1538-7445, 05/2008, Volume 68, Issue 9, pp. 3421 - 3428
Journal Article